Complement disorders and hereditary angioedema

Journal of Allergy and Clinical Immunology

Volumn 125, Issue 2 SUPPL. 2, 2010, Pages

  Frank, Michael M ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

atypical hemolytic uremic syndrome; Complement; complement deficiencies; hereditary angioedema

Indexed keywords

AMINOCAPROIC ACID; ANDROGEN; ANTIBODY; ANTIFIBRINOLYTIC AGENT; BRADYKININ B2 RECEPTOR ANTAGONIST; COMPLEMENT COMPONENT C1; COMPLEMENT COMPONENT C1S INHIBITOR; COMPLEMENT COMPONENT C2; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C3A; COMPLEMENT COMPONENT C4; COMPLEMENT COMPONENT C4A; COMPLEMENT COMPONENT C5A; COMPLEMENT RECEPTOR; DANAZOL; ECALLANTIDE; ICATIBANT; KALBITOR; LECTIN; MANNAN BINDING LECTIN ASSOCIATED SERINE PROTEINASE; MANNOSE BINDING LECTIN; RHUCIN; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; ANGIONEUROTIC EDEMA; ARTICLE; BIOLOGICAL ACTIVITY; CELL MEMBRANE; CIRCULATION; CLINICAL TRIAL; COMPLEMENT DEFICIENCY; COMPLEMENT DISORDER; CYTOLYSIS; DOWN REGULATION; FATIGUE; HUMAN; MICROORGANISM; MUSCLE WEAKNESS; NONHUMAN; PRIORITY JOURNAL;

ADAPTIVE IMMUNITY; ANGIOEDEMAS, HEREDITARY; ANIMALS; COMPLEMENT ACTIVATION; COMPLEMENT SYSTEM PROTEINS; CYTOTOXICITY, IMMUNOLOGIC; HUMANS; IMMUNOTHERAPY;

EID: 76749094964     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2009.10.063     Document Type: Article

References (37)

1. Frank M.M. Complement, introduction and historical notes. In: Volanakis J.A., and Frank M.M. (Eds). The human complement system in health and disease (1998), Marcel Decker, New York 1-8
2. Fujita T., Matsushita M., and Endo Y. The lectin-complement pathway-its role in innate immunity and evolution. Immunol Rev 198 (2004) 185-202
3. Walport M.J. Complement-first of two parts. N Engl J Med 344 (2001) 1058-1066
4. Walport M.J. Complement-second of two parts. N Engl J Med 344 (2001) 1140-1144
5. Thurman J.M., and Holers V.M. The central role of the alternative complement pathway in human disease. J Immunol 176 (2006) 1305-1310
6. Jensenius J.C. The mannan-binding lectin (MBL) pathway of complement activation: biochemistry, biology and clinical implications. Adv Exp Med Biol 564 (2005) 21-22
7. Hugli T.E. Biochemistry and biology of anaphylatoxins. Complement 3 (1986) 111-127
8. Nordahl E.A., Rydengard V., Nyberg P., Nitsche D.P., Morgelin M., Malmsten M., et al. Activation of the complement system generates antibacterial peptides. Proc Natl Acad Sci U S A 101 (2004) 16879-16884
9. Sjoholm A.G., Jonsson G., Braconier J.H., Sturfelt G., and Truedsson L. Complement deficiency and disease: an update. Mol Immunol 43 (2006) 78-85
10. Frank M.M. Complement deficiencies. Pediatr Clin North Am 47 (2000) 1339-1354
11. Carroll M. The complement system in regulation of adaptive immunity. Nat Immunol 5 (2004) 981-986
12. Holers V.M. Phenotypes of complement knockouts. Immunopharmacology 49 (2000) 125-131
13. Shushakova N., Skokowa J., Schulman J., Baumann U., Zwirner J., Schmidt R.E., et al. C5a anaphylatoxin is a major regulator of activating versus inhibitory FcγRs in immune complex-induced lung disease. J Clin Invest 110 (2002) 1823-1830
14. Davis A.E. C1 Inhibitor gene and hereditary angioedema. In: Volanakis J.A., and Frank M.M. (Eds). The human complement system in health and disease (1998), New York, Marcel Dekker 455-480
15. Blom A.M., Villoutreix B.O., and Dahlback B. Complement inhibitor C4b-binding protein-friend or foe in the innate immune system?. Mol Immunol 40 (2004) 1333-1346
16. Kim D.D., and Song W.C. Membrane complement regulatory proteins. Clin Immunol 118 (2006) 127-136
17. Barilla-LaBarca M.L., Liszewski M.K., Lambris J.D., Hourcade D., and Atkinson J.P. Role of membrane cofactor protein (CD46) in regulation of C4b and C3b deposited on cells. J Immunol 168 (2002) 6298-6304
18. Joiner K.A., Brown E.J., and Frank M.M. Complement and bacteria: chemistry and biology in host defense. Ann Rev Immunol 2 (1984) 461-484
19. He J.Q., Wiesmann C., and van Lookeren Campagne M. A role of macrophage complement receptor CRIg in immune clearance and inflammation. Mol Immunol 45 (2008) 4041-4047
20. Staunton D.E., Lupher M.L., Liddington R., and Gallatin W.M. Targeting integrin structure and function in disease. Adv Immunol 91 (2006) 111-157
21. Liszewski M.K., and Atkinson J.P. Regulatory proteins of complement. In: Volanakis J.A., and Frank M.M. (Eds). The human complement system in health and disease (1998), Marcel Dekker, New York 149-166
22. Dempsey P.W., Allison M.E., Akkaraju S., Goodnow C.C., and Fearon D.T. C3d of complement as a molecular adjuvant: bridging innate and acquired immunity. Science 271 (1996) 348-350
23. Fang C.J., Richards A., Liszewski M.K., Kavanagh D., and Atkinson J.P. Advances in understanding of pathogenesis of aHUS and HELLP. Br J Haematol 143 (2008) 336-348
24. Haines J.L., Hauser M.A., Schmidt S., Scott W.K., Olson L.M., Gallins P., et al. Complement factor H variant increases the risk of age-related macular degeneration. Science 308 (2005) 419-421
25. Luzzatto L. Paroxysmal nocturnal hemoglobinuria: an acquired X-linked genetic disease with somatic-cell mosaicism. Curr Opin Genet Dev 16 (2006) 317-322
26. Hillmen P., Young N.S., Schubert J., Brodsky R.A., Socie G., Muus P., et al. The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria. N Engl J Med 355 (2006) 1233-1243
27. Kohl J., Baelder R., Lewkowich I.P., Pandey M.K., Hawlisch H., Wang L., et al. A regulatory role for the C5a anaphylatoxin in type 2 immunity in asthma. J Clin Invest 116 (2006) 783-796
28. Peng T., Hao L., Madri J.A., Su X., Elias J.A., Stahl G.L., et al. Role of C5 in the development of airway inflammation, airway hyperresponsiveness, and ongoing airway response. J Clin Invest 115 (2005) 1590-1600
29. Carroll M. The role of complement and complement receptors in induction and regulation of immunity. Ann Rev Immunol 16 (1998) 545-568
30. Carroll M.C., and Holers V.M. Innate autoimmunity. Adv Immunol 86 (2005) 137-157
31. Nonaka M. Phylogeny of the complement system. In: Volanakis J.A., and Frank M.M. (Eds). The human complement system in health and disease (1998), Marcel Dekker, New York 203-216
32. Manderson A.P., Botto M., and Walport M.J. The role of complement in the development of systemic lupus erythematosus. Ann Rev Immunol 22 (2004) 431-456
33. Walport M., Davies K.A., and Botto M. C1q and systemic lupus erythematosus. Immunobiology 199 (1998) 256-285
34. Frank M.M. Hereditary angioedema: the clinical syndrome and its management in the United States. Immunol Allergy Clin North Am 26 (2006) 653-668
35. Zuraw B.L. Clinical practice. Hereditary angioedema. N Engl J Med 359 (2008) 1027-1036
36. Figueroa J., and Densen P. Infectious diseases associated with complement deficiencies. Clin Microbiol Rev 4 (1991) 369-395
37. Thurman J.M., and Holers V.M. The central role of the alternative complement pathway in human disease. J Immunol 176 (2006) 1305-1310